Fed. Circ. Tells PTAB To Review All Claims Of Drug Test Patent
The Federal Circuit ordered the Patent Trial and Appeal Board on Tuesday to review all challenged claims of a Rembrandt Diagnostics LP drug-testing patent, but did not rule on whether the...To view the full article, register now.
Already a subscriber? Click here to view full article